Pharmablue / Early & Expanded Access Programs in France / Group 12

Group 12

Group 12

27 June 2024

Pharmablue

Pharmablue

Did you like this article? Share on social networks:

email linkedin twitter link
Exploitant for Innovative Pharma Companies

Associated News

Benefits of using a third party Exploitant to run early access programs in France and more

Main benefits of outsourcing "Exploitant" status : Reminder : French regulatory authorities require having an...

Learn more
Ultimate Guide for European Early & Expanded Access Programs

Expanded Access is a treatment option that allows the use of an unauthorized medicine (investigational...

Learn more
Everything to know about exploitant status in France

About the "Exploitant" status French regulatory authorities require having an « Exploitant » authorized and...

Learn more